These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29153927)

  • 41. Depressive symptom trajectories associated with standard and accelerated rTMS.
    Kaster TS; Chen L; Daskalakis ZJ; Hoy KE; Blumberger DM; Fitzgerald PB
    Brain Stimul; 2020; 13(3):850-857. PubMed ID: 32289716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulating Emotion Perception: Opposing Effects of Inhibitory and Excitatory Prefrontal Cortex Stimulation.
    Notzon S; Steinberg C; Zwanzger P; Junghöfer M
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Apr; 3(4):329-336. PubMed ID: 29628065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation.
    Karris BC; Capobianco M; Wei X; Ross L
    J Psychiatr Pract; 2017 Mar; 23(2):141-144. PubMed ID: 28291040
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Actigraphy in Patients With Major Depressive Disorder Undergoing Repetitive Transcranial Magnetic Stimulation: An Open Label Pilot Study.
    Nishida M; Kikuchi S; Nisijima K; Suda S
    J ECT; 2017 Mar; 33(1):36-42. PubMed ID: 27611301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis.
    Gaynes BN; Lloyd SW; Lux L; Gartlehner G; Hansen RA; Brode S; Jonas DE; Swinson Evans T; Viswanathan M; Lohr KN
    J Clin Psychiatry; 2014 May; 75(5):477-89; quiz 489. PubMed ID: 24922485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Consensus statement on the application of rTMS in depression in the Netherlands and Belgium].
    Arns M; Bervoets C; van Eijndhoven P; Baeken C; van den Heuvel OA; Aleman A; Schutter DJLG; van der Werf Y; van Belkum S; Sommer IE; van Ruth R; Haarman B; Spijker J; Sack AT
    Tijdschr Psychiatr; 2019; 61(6):411-420. PubMed ID: 31243751
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An open-label feasibility study of repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression in the New Zealand healthcare context.
    Godfrey KE; Muthukumaraswamy SD; Stinear CM; Hoeh NR
    N Z Med J; 2019 Oct; 132(1504):46-55. PubMed ID: 31647794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Duprat R; Desmyter S; Rudi de R; van Heeringen K; Van den Abbeele D; Tandt H; Bakic J; Pourtois G; Dedoncker J; Vervaet M; Van Autreve S; Lemmens GM; Baeken C
    J Affect Disord; 2016 Aug; 200():6-14. PubMed ID: 27107779
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between individual alpha peak frequency and clinical outcome with repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder (MDD).
    Corlier J; Carpenter LL; Wilson AC; Tirrell E; Gobin AP; Kavanaugh B; Leuchter AF
    Brain Stimul; 2019; 12(6):1572-1578. PubMed ID: 31378603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
    Mogg A; Pluck G; Eranti SV; Landau S; Purvis R; Brown RG; Curtis V; Howard R; Philpot M; McLoughlin DM
    Psychol Med; 2008 Mar; 38(3):323-33. PubMed ID: 17935639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prefrontal cortical blood flow predicts response of depression to rTMS.
    Weiduschat N; Dubin MJ
    J Affect Disord; 2013 Sep; 150(2):699-702. PubMed ID: 23707032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT.
    Brunelin J; Jalenques I; Trojak B; Attal J; Szekely D; Gay A; Januel D; Haffen E; Schott-Pethelaz AM; Brault C; ; Poulet E
    Brain Stimul; 2014; 7(6):855-63. PubMed ID: 25192980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dorsolateral prefrontal γ-aminobutyric acid in patients with treatment-resistant depression after transcranial magnetic stimulation measured with magnetic resonance spectroscopy.
    Levitt JG; Kalender G; O’Neill J; Diaz JP; Cook IA; Ginder N; Krantz D; Minzenberg MJ; Vince-Cruz N; Nguyen LD; Alger JR; Leuchter AF
    J Psychiatry Neurosci; 2019 Nov; 44(6):386-394. PubMed ID: 31199104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial.
    Kaster TS; Daskalakis ZJ; Noda Y; Knyahnytska Y; Downar J; Rajji TK; Levkovitz Y; Zangen A; Butters MA; Mulsant BH; Blumberger DM
    Neuropsychopharmacology; 2018 Oct; 43(11):2231-2238. PubMed ID: 29946106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Equivalent beneficial effects of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in a large randomized trial in treatment-resistant major depression.
    Fitzgerald PB; Hoy KE; Singh A; Gunewardene R; Slack C; Ibrahim S; Hall PJ; Daskalakis ZJ
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1975-84. PubMed ID: 23663510
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression.
    Fitzgerald PB; Benitez J; de Castella A; Daskalakis ZJ; Brown TL; Kulkarni J
    Am J Psychiatry; 2006 Jan; 163(1):88-94. PubMed ID: 16390894
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High frequency repetitive transcranial magnetic stimulation treatment for major depression: Dissociated effects on psychopathology and neurocognition.
    Tovar-Perdomo S; McGirr A; Van den Eynde F; Rodrigues Dos Santos N; Berlim MT
    J Affect Disord; 2017 Aug; 217():112-117. PubMed ID: 28407553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies for augmentation of high-frequency left-sided repetitive transcranial magnetic stimulation treatment of major depressive disorder.
    Lee JC; Wilson AC; Corlier J; Tadayonnejad R; Marder KG; Pleman CM; Krantz DE; Wilke SA; Levitt JG; Ginder ND; Leuchter AF
    J Affect Disord; 2020 Dec; 277():964-969. PubMed ID: 33065840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous rTMS and psychotherapy in major depressive disorder: Clinical outcomes and predictors from a large naturalistic study.
    Donse L; Padberg F; Sack AT; Rush AJ; Arns M
    Brain Stimul; 2018; 11(2):337-345. PubMed ID: 29174304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.